Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 21 (4), 496-499
- https://doi.org/10.1016/s0168-8278(94)80092-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Immunosupressive therapy for primary biliary cirrhosisJournal of Hepatology, 1992
- Treatment of primary biliary cirrhosis with low-dose weekly methotrexateGastroenterology, 1991
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1991
- A Controlled Trial of Cyclosporine in the Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1990
- Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trialGastroenterology, 1989
- A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone lossHepatology, 1989
- Therapy of chronic graft-v-host disease in a rat modelBlood, 1989
- THALIDOMIDH FOR GRAFT-VERSUS-HOST DISEASEThe Lancet, 1988
- Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosisHepatology, 1988
- SUCCESSFUL TREATMENT WITH THALIDOMIDE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATIONThe Lancet, 1988